FV6-10652-76537
4 vaccinations
7 coded responses
40 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Registered in v-safe
-
2021-04-23
Dose 1 — Moderna
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
-
2021-04-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
-
2021-05-21
Dose 2 — Moderna
- 2021-05-21
-
2021-05-22
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Chills, Muscle or body achesFree text: SweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-05-27
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-07-02
- 2021-08-20
-
2021-11-19
Survey response — 6 months, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Had a little sore throat for a day or two.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-29
Dose 3 — Moderna
-
2021-12-29
Survey response — day 0, dose 3MedDRA: Injection site pain — Feeling: GoodFree text: Just a bit of sore arm where injectedMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased, Initial insomnia — Feeling: Good · Site: PainFree text: Heart beat higher than usual when going to bed last night after booster. Nothing major but noticed and had trouble falling asleepMedDRA releases: 2024-11 · check-in free text available
- 2021-12-31
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-04
- 2022-01-05
-
2022-01-12
Survey response — day 14, dose 3MedDRA: Exposure to SARS-CoV-2, Fatigue, Hot flush, Hyperhidrosis, Oropharyngeal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Was notified that I've been exposed to someone who tested positive for covid. Had sore throat, tiredness and hot flashes/sweats for one dayMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-14
- 2022-01-21
- 2022-01-26
- 2022-02-02
- 2022-02-09
-
2022-03-30
Survey response — 3 months, dose 3MedDRA: Eczema — Feeling: FairFree text: EczemaMedDRA releases: 2024-11 · check-in free text available
-
2022-06-29
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: GoodFree text: Had a sore throat for two days, tested neg for covid with home testMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Dose 4 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Moderna | |
| 2 | 2021-05-21 | Moderna | |
| 3 | 2021-12-29 | Moderna | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Sweats
Release 10 — 6 months, dose 2
Symptoms: Had a little sore throat for a day or two.
Release 10 — day 0, dose 3
Systemic reaction (other): Just a bit of sore arm where injected
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Heart beat higher than usual when going to bed last night after booster. Nothing major but noticed and had trouble falling asleep
Release 10 — day 14, dose 3
Symptoms: Was notified that I've been exposed to someone who tested positive for covid. Had sore throat, tiredness and hot flashes/sweats for one day
Release 11 — 3 months, dose 3
Symptoms: Eczema
Release 12 — 6 months, dose 3
Symptoms: Had a sore throat for two days, tested neg for covid with home test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eczema | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hot flush | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Initial insomnia | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release